All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
Introducing
Now you can personalise
your AML Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The AML Hub is an independent medical education platform, sponsored by Daiichi Sankyo, Jazz Pharmaceuticals, Kura Oncology, Roche and Syndax and has been supported through a grant from Bristol Myers Squibb. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Bookmark this article
During a meeting of the AML Hub Steering Committee on June 1, 2022, Gail Roboz, Weill Cornell Medicine, New York, US, chaired a discussion session on the topic of “How to provide better supportive care”, which was identified as an unmet educational need within AML treatment.
Roboz starts by introducing “supportive care” as a subject that is often overlooked when presenting information to clinicians and patients, and then invites the committee to comment on the prophylaxis of infectious diseases in their own clinical practice. The committee then offers recommendations for coping with diagnosis and intensive chemotherapy, exploring subjects such as the evolving literature on this topic, and the patient’s need for continuity. Finally, they cover the diet in patients with AML, and Uwe Platzbecker concludes by highlighting the impact that excessive use of prophylactic supplementation can have on the microbiome and recommending careful selection within treatment plans.
How to provide better supportive care
Your opinion matters
Subscribe to get the best content related to AML delivered to your inbox